Neutrophil elastase promotes interleukin-1β secretion from human coronary endothelium

Mabruka Alfaidi1, Heather Wilson1, Marc Daigneault1

  • 1From the Department of Cardiovascular Science, Medical School, University of Sheffield, Sheffield S10 2RX, United Kingdom.

Insights

Neutrophil elastase (NE) triggers the release of inflammatory interleukin-1 beta (IL-1β) from endothelial cells via extracellular vesicles. This discovery offers new therapeutic targets for atherosclerosis and vascular disease.

Area of Science:

  • Cardiovascular Biology
  • Inflammation Research
  • Endothelial Cell Biology

Background:

  • Endothelium plays a key role in atherosclerosis pathogenesis by releasing pro-inflammatory mediators like IL-1β.
  • High levels of IL-1β are found in the endothelium of coronary arteries from patients with ischemic heart disease.
  • The precise mechanism of IL-1β release from endothelial cells is not fully understood.

Purpose of the Study:

  • To investigate the role of neutrophil elastase (NE) in processing and releasing IL-1β from human coronary endothelium.
  • To test the hypothesis that NE potentiates IL-1β processing and release.

Main Methods:

  • Investigated NE's effect on pro-IL-1β processing in endothelial cells (ECs).
  • Assessed IL-1β secretion via extracellular vesicles.
  • Utilized NE inhibition and monitored intracellular Ca(2+) levels.
  • Examined IL-1β localization within ECs and in vivo atherosclerotic plaques.

Main Results:

  • NE cleaves pro-IL-1β in ECs, leading to bioactive IL-1β secretion via extracellular vesicles.
  • NE inhibition significantly reduced IL-1β release, while caspase-1 inhibition did not.
  • Increased intracellular Ca(2+) preceded IL-1β secretion.
  • NE treatment resulted in IL-1β localization within LAMP-1-positive multivesicular bodies in ECs.
  • Released extracellular vesicles contained bioactive IL-1β.
  • In vivo, NE and IL-1β were co-localized in the endothelium of atherosclerotic plaques.

Conclusions:

  • NE acts as a trigger for the processing and release of bioactive IL-1β from endothelial cells through extracellular vesicles.
  • This NE-dependent pathway represents a novel mechanism linking NE in atherosclerotic plaques to endothelial inflammation.
  • Findings suggest potential new therapeutic strategies targeting NE or IL-1β secretion in vascular disease.